Pharmaceutical CDMO Market Key Developments and Industry Trends

Pharmaceutical CDMO Market: Key Players, Benefits, and Segment Insights

The global pharmaceutical Contract Development and Manufacturing Organization (CDMO) market was valued at approximately USD 146.05 billion in 2023 and is expected to expand to USD 315.08 billion by 2034. This growth represents a compound annual growth rate (CAGR) of 7.24% from 2024 to 2034. The market is driven by the increasing demand for pharmaceutical products, as more companies seek specialized partners for drug development and manufacturing. https://www.towardshealthcare.com/insights/pharmaceutical-cdmo-market-sizing https://www.towardshealthcare.com/insights/pharmaceutical-cdmo-market-sizing

Pharmaceutical CDMO Market: A Valuable Partner for Pharma Companies

Pharmaceutical companies face challenges in developing new therapeutic products. Partnering with a Contract Development and Manufacturing Organization (CDMO) helps overcome these hurdles by providing expertise, scalability, and cost savings. CDMOs allow companies to access advanced technologies and production capacity while minimizing risk.

Pharmaceutical CDMO Market Trends

In October 2024, Strides Pharma Science raised Rs 801 crore from investors for its affiliate company. In June 2023, Saudi Arabia’s Public Investment Fund launched Lifera to boost the country’s pharmaceutical manufacturing sector. In March 2023, Pharmaron expanded its UK gene therapy production facilities with a £151 million investment.

Recent Announcements by Industry Leaders

In October 2023, CPHI Barcelona is expected to draw over 40,000 executives from across the pharmaceutical supply chain. This major event, held at Fira Barcelona from October 24 to 26, has become an essential meeting point for discussions on outsourcing, as well as the pharmaceutical and biotech industries.

Recent Developments in the Pharmaceutical CDMO Market

In October 2023, Norstella's firm, Evaluate, launched the CDMO Intelligence solution. This tool is designed to provide CDMOs, biopharma companies, and financial institutions with comprehensive market insights, helping them make informed decisions and develop effective long-term strategies in the rapidly evolving pharmaceutical CDMO sector. In September 2023, Future Fields, a biotechnology company, introduced a new CDMO service. The company, known for pioneering the world's first synthetic biology system using fruit flies to create recombinant proteins, aims to offer innovative solutions in the field. Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/pharmaceutical-cdmo-market-sizing Access exclusive insight now @ https://www.towardshealthcare.com/price/5327 We’ve prepared a service to support you. Please feel free to contact us at [email protected] Web: https://www.towardshealthcare.com Visit Dental Specifics: https://www.towardsdental.com Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

FAQ's

Answer : According to Precedence Research, the global automotive V2X market value is expected to surpass US$ 15.3 billion by 2030.

Answer : The global automotive V2X market is expected to grow at a CAGR of 45% over forecast period 2022 to 2030.

Answer : Increasing sales of passenger as well as commercial vehicles across the globe contribute significantly to drive the market. Increasing traffic congestion, greenhouse gas emission rising number of accidents have forced governments of various regions to impose stringent safety and emission norms. V2X technology helps driver to improve safety of the vehicle as well as it reduces the greenhouse gas emission from the vehicle, thereby accelerating the demand of the technology in the coming years. Furthermore, the concept of driverless cars and autonomous vehicles are still under their research phase and expected to take years to be commercialized.

Answer : Some of the key players operating in the market are Continental AG, Qualcomm, Inc., Delphi Automotive LLP, NXP Semiconductors, TomTom International B.V., Robert Bosch GmbH, HARMAN International, Cisco Systems, Inc., Mobileye, and Infineon Technologies AG among others.

Answer : In 2019, North America led the global automotive V2X market with significant revenue share in the year 2019. Ease of technology adoption along with the region being one of the largest markets for automobile are some of the prime factors that drives the growth of the region.

Answer : Based on vehicle type, passenger vehicles accounted for the largest market value share of nearly 75% in the year 2019 and analyzed to continue its dominance during the forecast period.

Answer : By communication type, Vehicle-To-Vehicle (V2V) projected to dominate the global automotive V2X market during the forecast period.

Answer : Based on connectivity type, Dedicated Short Range Connectivity (DSRC) seeks to capture maximum revenue share in the present as well as during the forecast period. Ease of implementation along with cost benefits of DSRC over the cellular connectivity expected to drive the growth of the segment.